Navigation Links
Dendreon Presents Preclinical Data Demonstrating Activity of Trp-p8 agonist, D-3263, in Benign Prostatic Hyperplasia
Date:5/21/2008

- Data Presented at American Urological Association Annual Meeting -

SEATTLE and ORLANDO, Fla., May 21 /PRNewswire-FirstCall/ -- Researchers from Dendreon Corporation (Nasdaq: DNDN) today presented preclinical data demonstrating the potential of D-3263, Dendreon's orally bioavailable small molecule, which targets Trp-p8 (a transmembrane cation channel protein also known as Trp-M8), to treat benign prostatic hyperplasia (BPH).

The abstract (#2041), "Preclinical Validation of the Trp-p8 Ion Channel as a Target for Benign Prostatic Hyperplasia," is being presented at the American Urological Association's 2008 Annual Meeting in Orlando, Fla., on Wednesday, May 21, 2008, at 2:50 PM ET.

In a preclinical study, BPH was induced through subcutaneous injection of testosterone propionate (TP). One week prior to initiation of testosterone, either D-3263 or finasteride, a current treatment for BPH, was administered daily for four weeks. Following treatment, blood was sampled, prostates were collected and weighed, and cross sections were stained with Trp-p8 antibody.

"We are encouraged by these data which demonstrate the potential for D-3263, our lead small molecule targeting Trp-p8, to serve as a drug candidate for the potential treatment of BPH -- a disease affecting a substantial number of men between 50 and 60 years of age," said David Urdal, chief scientific officer of Dendreon. "We had previously shown that D-3263 specifically kills cancer cells that express Trp-p8, and we look forward to filing an investigational new drug application later this year to initiate a study examining D-3263 in advanced cancer, including prostate cancer."

Results showed that the BPH-induced prostates expressed significantly higher le
'/>"/>

SOURCE Dendreon Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Dendreon Presents Data Correlating the Cumulative Potency of PROVENGE(R) to Overall Survival
2. Dendreon Completes Target Enrollment of 500 Patients in Phase 3 IMPACT Study of Provenge(R) For Advanced Prostate Cancer
3. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
4. Ardea Biosciences Presents Preclinical Data on RDEA119 Demonstrating Favorable Anti-Inflammatory Profile for Potential Use in Ulcerative Colitis
5. Indevus Presents Successful Phase III NEBIDO(R) Data at American Urological Association
6. Neurobiological Technologies, Inc. Presents Dosing Rationale for Viprinex(TM) (ancrod) at the European Stroke Conference
7. Napo Presents at ISPOR Meeting in Toronto
8. Alpharma Presents Data Addressing Abuse Liability Features, Safety and Efficacy on ALO-01 (EMBEDA(TM)) (morphine sulfate extended-release with sequestered naltrexone hydrochloride) at the American Pain Society Annual Scientific Session
9. Dr. Calvin Grant Presents Results from Xibrom(TM) Combination Therapy with Lucentis(R) at the 2008 Annual Meeting of the Association for Research in Vision and Ophthalmology (ARVO)
10. Pharmasset Presents Results of 4-Week Combination Study of R7128 for the Treatment of Chronic Hepatitis C
11. Idenix Pharmaceuticals Presents Positive Preclinical Data on HCV Programs at The Annual Meeting of The European Association for the Study of the Liver (EASL)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/2/2015)... 3, 2015 Pharma Major ... de participación en ZAO "Biocom" en Rusia bajo ... incursión de Lupin en el mercado farmacéutico de ... ventas, colocándolo como uno de los 10 principales ... Durante más de una década, el mercado farmacéutico ...
(Date:7/2/2015)... 2, 2015  New product launches are critical events ... in educating thought leaders about new products, Medical Affairs ... how well a new therapy performs at launch. ... and consulting leader Best Practices, LLC, critical aspects of ... on are early stage thought leader (TL) interaction, successful ...
(Date:7/2/2015)... , July 2, 2015 According to ... Technology (Deep Brain Stimulation, Spinal Cord Stimulation, Transcranial Magnetic Stimulation), ... Global Forecast to 2020", published by MarketsandMarkets, the global Neuromodulation ... projected to reach $6.20 Billion by 2020, at a CAGR ... 8 4 market data T ...
Breaking Medicine Technology:Lupin adquiere Biocom en Rusia 2Lupin adquiere Biocom en Rusia 3Medical Affairs Role in Thought Leader Education is Key Success Factor for New Product Launches in the Pharmaceutical Industry 2Neuromodulation Market Worth $6.20 Billion by 2020 2Neuromodulation Market Worth $6.20 Billion by 2020 3Neuromodulation Market Worth $6.20 Billion by 2020 4
(Date:7/3/2015)... ... 03, 2015 , ... Yisrayl Hawkins, Pastor and Overseer at The House of ... will reveal biblical truth and expose popular lies regarding proper relationships according to the ... Sex”, immediately goes into the core of the subject by explaining why certain types ...
(Date:7/2/2015)... ... ... sweetFrog Enterprises, LLC. is pleased to announce the opening of its newest location ... The premium frozen yogurt chain was listed as #22 on the Inc. 500 list ... New Albany, MS 38652, will have a grand opening event on July 4, 2015 ...
(Date:7/2/2015)... ... ... Following the recent report by JAMA Internal Medicine published on June 22, ... emphatically declared a war on obesity in the United States. , "Obesity is one ... the magnitude of this discovery. For that reason, I am declaring, along with my ...
(Date:7/2/2015)... ... ... Many Fourth of July celebrations will include fireworks this summer, so it’s ... some tips to promote the proper use of fireworks. , According to the U.S. ... with fireworks-related injuries in the month surrounding the Fourth of July. Amica is sharing ...
(Date:7/2/2015)... ... ... “ LIFX ” was featured on NewsWatch as part of its monthly Tech Report, ... technology expert and special reporter for NewsWatch, conducted the review and shared with viewers ... , According to the U.S. Department of Energy, it’s very important to use energy-efficient ...
Breaking Medicine News(10 mins):Health News:Yisrayl Hawkins Explains What the Bible Really Says about Sex in New Publication This Week 2Health News:sweetfrog Opens First Location in Mississippi 2Health News:Samir Becic's Health Fitness Revolution Declares War Against Obesity in America 2Health News:Samir Becic's Health Fitness Revolution Declares War Against Obesity in America 3Health News:Samir Becic's Health Fitness Revolution Declares War Against Obesity in America 4Health News:6 Fireworks Safety Tips from Amica Insurance 2Health News:The Most Versatile Smart Light Bulbs were featured on NewsWatch Television 2
... for embryonic development can quickly become a potent cancer promoter ... from Fox Chase Cancer Center, causing white blood cells to ... the journal Cancer Research, the researchers detail how a gene ... drive cancer in mice. The protein that Dlx5 encodes could ...
... leave nation vulnerable to disease, bioterror and health, threats according to ... ... Public Health, WASHINGTON, Feb. 27 While natural disasters,the threat ... resources, the U.S. is facing a major public health,workforce crisis that could ...
... 27 Riverview Medical,Center, located in Red ... under the J.D. Power and Associates Distinguished ... by Riverview,Medical Center to provide an "outstanding ... ), The service excellence distinction was ...
... Vaccination Programs Using FluMist(R) May Serve as Model ... Help Vaccinate Large Numbers of Eligible ... MedImmune, the manufacturer,of FluMist(R) (Influenza Virus Vaccine Live, ... and Prevention,s (CDC) Advisory Committee,on Immunization Practices (ACIP) ...
... to health care might help to overcome racial and ethnic ... the March 2008 issue of Clinical Journal of the American ... "yet another wake-up call as to how we as a ... nation, including the reduction and/or elimination of health disparities," according ...
... KAN. -- Despite millions of dollars spent on food safety ... to E. coli O157:H7 were higher in 2007 than in ... Texas A&M University. E. coli O157:H7 has been linked to ... , "We have been studying the effects of a novel ...
Cached Medicine News:Health News:Inverted DNA turns quiet developmental gene into a potent driver of t-cell lymphoma 2Health News:More Than 250,000 Additional Public Health Workers Needed by 2020 to Avert Public Health Crisis 2Health News:More Than 250,000 Additional Public Health Workers Needed by 2020 to Avert Public Health Crisis 3Health News:J.D. Power and Associates Reports: Riverview Medical Center Recognized for Providing an Emergency Department Experience 2Health News:J.D. Power and Associates Reports: Riverview Medical Center Recognized for Providing an Emergency Department Experience 3Health News:MedImmune Prepared to Support Implementation of Expanded ACIP Recommendations for Influenza Vaccinations 2Health News:MedImmune Prepared to Support Implementation of Expanded ACIP Recommendations for Influenza Vaccinations 3Health News:MedImmune Prepared to Support Implementation of Expanded ACIP Recommendations for Influenza Vaccinations 4Health News:Race, insurance status affect access to transplantation and kidney disease treatment 2Health News:Race, insurance status affect access to transplantation and kidney disease treatment 3Health News:Researchers collaborate to find new vaccine technology decreases E. coli in beef cattle 2
Lorgnette pinhole occluder...
Long handle occluder - Black...
Long handle occluder - White...
6 inch hand held occlcuder with 49 holes...
Medicine Products: